Short and long term treatment of asthma with intravenous nutrients

Shrader, Welman A

doi:10.1186/1475-2891-3-6

Nutrition Journal

Table 2 Pre-/Post IV Treatment Data – 39 Patients Percent Predicted, Pre- and Post- infusion with % improvement

From: Short and long term treatment of asthma with intravenous nutrients

			FVC (L)			FEV 1 (L)			PEF (L/S)			FEF 25–75 (L/S)			FEF 75–85 (L/S)
	Sex	Age	% Predicted			% Predicted			% Predicted			% Predicted			% Predicted
Patient			Pre	Post	%	Pre	Post	%	Pre	Post	%	Pre	Post	%	Pre	Post	%
A, L.	M	55	36	72	100%	36	79	119%	64	92	44%	35	129	269%	32	112	250%
A, S.	F	48	28	50	79%	30	48	60%	40	78	95%	30	40	33%	40	38	-5%
B, M.	F	57	69	100	45%	48	81	69%	45	115	156%	24	39	63%	30	32	7%
B, R.	M	46	73	93	27%	69	87	26%	95	106	12%	57	70	23%	66	67	2%
B, V.	F	39	34	67	97%	34	72	112%	51	59	16%	38	96	153%	26	98	277%
B, V.	F	70	38	54	42%	32	47	47%	32	53	66%	18	30	67%	25	34	36%
C, D.	M	59	27	30	11%	14	17	21%	10	12	20%	10	10	0%	32	28	-13%
C, A.	F	33	90	91	1%	80	98	23%	115	142	23%	60	108	80%	65	116	78%
C, K.	F	35	45	62	38%	34	52	53%	32	56	75%	22	36	64%	32	41	28%
D, C.	F	33	65	65	0%	49	56	14%	62	65	5%	31	41	32%	42	51	21%
D, B.	M	49	65	80	23%	72	83	15%	68	88	29%	75	80	7%	146	147	1%
D, K.	F	48	61	74	21%	56	70	25%	89	95	7%	39	60	54%	29	33	14%
F, L.	M	58	26	29	12%	12	13	8%	7	8	14%	7.4	8.1	9%	22	26	18%
G, W.	M	74	48	67	40%	25	57	128%	16	88	450%	11	37	236%	38	63	66%
G, B.	M	45	83	113	36%	83	101	22%	94	149	59%	81	70	-14%	89	60	-33%
G, G.	F	42	83	93	12%	46	82	78%	24	59	146%	31	66	113%	55	79	44%
G, L.	F	63	50	78	56%	36	60	67%	52	71	37%	17	29	71%	21	29	38%
J, E.	F	63	47	85	81%	38	84	121%	43	64	49%	19	79	316%	20	55	175%
K, H.	F	49	58	72	24%	59	72	22%	82	99	21%	53	62	17%	76	86	13%
M, A.	F	46	85	97	14%	79	89	13%	61	86	41%	71	71	0%	73	68	-7%
M, W.	M	85	74	77	4%	69	90	30%	46	82	78%	50	119	138%	148	458	209%
M, C.	F	36	93	85	-9%	52	53	2%	30	46	53%	26	25	-4%	26	25.5	-2%
M, J.	M	64	74	75	1%	49	57	16%	47	60	28%	25	37	48%	57	83	46%
O, M	F	49	90	99	10%	98	114	16%	88	167	90%	114	168	47%	145	214	48%
P, O.	F	47	54	72	33%	52	76	46%	85	84	-1%	46	82	78%	40	74	85%
R, B.	F	69	21	23	10%	16	19	19%	13	17	31%	10	11	10%	21	22	5%
S, M.	F	60	56	94	68%	45	88	96%	60	104	73%	26	66	154%	26	51	96%
S, J.	M	54	98	166	69%	76	96	26%	77	70	-9%	34	39	15%	70	90	29%
S, S.	M	40	73	85	16%	58	69	19%	68	85	25%	36	40	11%	43	38	-12%
S, D.	F	64	40	56	40%	25	33	32%	18	21	17%	15	14	-7%	42	34	-19%
S, W.	M	44	71	80	13%	52	65	25%	42	60	43%	31	40	29%	31	38	23%
T, P.	F	45	41	59	44%	26	46	77%	22	73	232%	17	27	59%	26	32	23%
W, P.	F	65	48	76	58%	17	31	82%	9	21	133%	9	11	22%	20	19	-3%
W, B.	M	38	54	72	33%	42	58	38%	32	46	44%	25	37	48%	37	50	35%
W, R.	M	40	77	77	0%	34	41	21%	27	33	22%	12	16	33%	21	24	14%
W, C.	F	55	28	39	39%	20	28	40%	17	26	53%	12	16	33%	20	23	15%
W, G.	F	70	101	108	7%	78	98	26%	34	82	141%	51	65	27%	49	62	27%
Z, A.	F	43	62	75	21%	64	75	17%	107	87	-19%	68	88	29%	57	49	-14%
Average:		52	60	76	28%	48	65	38%	50	72	44%	35	54	54%	48	70	44%
Average Overall Improvement					45%

Results were measured as percentage improvement of the percentage predicted on the Knudsen scale

Back to article page

ISSN: 1475-2891

Contact us

General enquiries: journalsubmissions@springernature.com